Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,795,576
Total 13F shares
3,787,461
Share change
-353
Total reported value
$46,318,646
Put/Call ratio
111%
Price per share
$12.20
Number of holders
50
Value change
-$4,286
Number of sells
1

Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q4 2013

As of 31 Dec 2013, Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,787,461 shares. The largest 10 holders included FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, BlackRock Fund Advisors, Wood Investment Counsel LLC, NORTHERN TRUST CORP, State Street Corp, Harvest Capital Strategies LLC, BANK OF AMERICA CORP /DE/, and BlackRock Institutional Trust Company, N.A.. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.